• Ibrutix 140mg (Ibrutinib): Blood Cancer Therapy Quick View
    • Ibrutix 140mg (Ibrutinib): Blood Cancer Therapy Quick View

    • Ibrutix 140mg (Ibrutinib): Blood Cancer Therapy

    • Ibrutix 140mg (Ibrutinib) is a breakthrough oral medication used for the treatment of specific blood cancers such as Chronic Lymphocytic Leukemia (CLL), Mantle Cell Lymphoma (MCL), and Waldenström's Macroglobulinemia (WM). Ibrutinib, the active ingredient in Ibrutix, is a targeted therapy that works by inhibiting Bruton's Tyrosine Kinase (BTK), a protein essential for the growth and survival of cancerous B-cells. By…
    • Read more